This drug for blood disorder shows promise in phase 1-2 clinical trial
A drug called rilzabrutinib has generated promising safety and efficacy results in a recent international multi-centre phase 1-2 immune thrombocytopenia ...
Tag: This drug for blood disorder shows promise in phase 1-2 clinical trial
